The State of Prescreening Discussions About Prostate-specific Antigen Testing Following Implementation of the 2012 United States Preventive Services Task Force Statement.
To determine if the quality of prescreening discussions has changed following release of the United States Preventive Services Task Force statement against prostate cancer screening.



This cross-sectional study used the 2012 and 2014 Behavioral Risk Factor Surveillance System surveys. Respondents were categorized based on the year in which they responded to the Behavioral Risk Factor Surveillance System Survey. Quality of prescreening discussion was operationalized as having discussed only advantages, only disadvantages, both advantages and disadvantages, or neither. Race/ethnicity, education level, income, insurance status, and having a prostate-specific antigen (PSA) level actually drawn after prescreening counseling served as confounders in our multivariate analysis.



Among 217,053 men in the analytic sample, 37% were told about only advantages of PSA screening compared to 30% of men who were advised about both advantages and disadvantages. Men who were told about neither advantages nor disadvantages were more likely to be Hispanic, not graduate high school, have low income, and not have insurance. Controlling for covariates, men in 2014 were significantly more likely to have undergone PSA testing without having discussed either advantages or disadvantages than men in 2012.



Comprehensive prescreening discussions about advantages and disadvantages of PSA testing are critical to informed decision making about prostate cancer screening. Disparities not only exist with regard to the quality of prescreening discussions that patients receive from their providers prior to PSA testing across categories of race/ethnicity, education, income, and insurance status, but these disparities became more substantial between 2012 and 2014. Further investigation is warranted to elicit more specific reasons behind these variations.
Minimally Invasive Urology Institute, Division of Urology, Brown University, Providence, RI. Electronic address: Geoturini@gmail.com.
George A
GA
Turini
Department of Epidemiology, Brown University School of Public Health, Providence, RI.
Annie
A
Gjelsvik
Minimally Invasive Urology Institute, Division of Urology, Brown University, Providence, RI.
Joseph F
JF
Renzulli
D000328:Adult; D026683:Advisory Committees; D000368:Aged; D003430:Cross-Sectional Studies; D003657:Decision Making; D055088:Early Detection of Cancer / Q000379:methods*; D015438:Health Behavior; D006801:Humans; D008297:Male; D008403:Mass Screening; D008875:Middle Aged; D015999:Multivariate Analysis; D017410:Practice Guidelines as Topic; D011315:Preventive Medicine / Q000379:methods* / Q000592:standards*; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000175:diagnosis*; D012307:Risk Factors; D011795:Surveys and Questionnaires; D014481:United States
D017430:Prostate-Specific Antigen